SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-202461
Filing Date
2017-06-13
Accepted
2017-06-13 16:17:33
Documents
4
Period of Report
2017-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d391321d8k.htm 8-K 16220
2 EX-99.1 d391321dex991.htm EX-99.1 7396
3 GRAPHIC g391321g28v31.gif GRAPHIC 4582
4 GRAPHIC g391321g89k85.gif GRAPHIC 3676
  Complete submission text file 0001193125-17-202461.txt   36812
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 17909023
SIC: 2836 Biological Products, (No Diagnostic Substances)